Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASPIRE extension study of aliskiren after acute myocardial infarction
NL-OMON32303Phase 3Active, not recruiting
- Sponsor
- Novartis
- Start
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of aliskiren in myocardial infarction (MI), sponsored by Novartis. Started May 2008; status: active, not recruiting.
02
Drugs
aliskiren
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NL-OMON32303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32303.